Heart disease is once again the leading cause of death in the U.S., according to a new statistical report from the American ...

Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

A study that reviews the sodium and nutritional content of foods promoted during timeouts and halftime found that adults may ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...

A NEW SET OF TARIFFS BY THE TRUMP ADMINISTRATION WILL TAKE EFFECT, AND THEY COULD DRAMATICALLY CHANGE THE WAY YOU GET ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Dr Eric Berg DC has warned suffering from the condition every night could put you more at risk of several chronic diseases ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.